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Bcl-2 influences axonal growth rate in embryonic sensory
neurons
Mark Hilton, Gayle Middleton and Alun M. Davies
Bcl-2 plays a key role in regulating cell survival in the
immune and nervous systems. Mice lacking the bcl-2
gene have markedly reduced numbers of B and T cells as
a result of increased apoptosis [1–3], whereas mice with
a transgene causing high levels of Bcl-2 expression in
the immune system show extended survival of B and T
cells [4,5]. Overexpression of Bcl-2 in cultured neurons
prevents their death following neurotrophin deprivation
[6,7], and mice with a bcl-2 transgene under the control
of a neuron-specific enolase promoter have increased
numbers of neurons in several regions [8]. Cultured
neurons expressing antisense bcl-2 RNA have an
attenuated survival response to neurotrophins [9], and
neurons of postnatal bcl-2-deficient mice die more
rapidly following NGF deprivation in vitro [10] and are
present in reduced numbers in vivo [11]. Here, we show
that Bcl-2 also plays a role in regulating axonal growth
rates in embryonic neurons. Sensory neurons from the
trigeminal ganglia of bcl-2-deficient mouse embryos,
removed from the embryo on embryonic day 11 or 12,
extend axons more slowly in vitro than do neurons from
wild-type embryos of the same age. Serial
measurements of axonal length in the same neurons
revealed that there were marked differences in axonal
growth rate between bcl-2-deficient and wild-type
neurons, irrespective of whether the neurons were grown
with nerve growth factor, brain-derived neurotrophic
factor or neurotrophin-3. Because there was no
significant difference in the numbers of wild-type and
bcl-2-deficient neurons surviving with each neurotrophin
at this early stage of development, the effect of Bcl-2 on
axonal growth rate is not a consequence of its well
documented role in preventing apoptosis.
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Results and discussion
In the course of studying early sensory neurons from bcl-2-
null mutant (bcl-2–/–) mouse embryos in vitro, we observed
that these neurons had shorter axons than wild-type
neurons. To ascertain whether this was due to a reduced
rate of axonal growth, we carried out a detailed compara-
tive study of axonal growth rate in low-density dissociated
cultures of trigeminal ganglion neurons established from
bcl-2–/– and wild-type embryos at embryonic day 11 or 12
(E11 or E12), when many trigeminal axons are growing to
their peripheral and central targets in vivo [12]. Because
some neurons are generated from progenitor cells in disso-
ciated cultures of early trigeminal ganglia [13] and start
extending axons at different times in the cultures, it was
essential to make serial measurements of axonal length of
the same neurons at intervals in culture in order to obtain
an accurate measure of axonal growth rate. Because many
trigeminal neurons switch from being dependent for sur-
vival on brain-derived neurotrophic factor (BDNF) and
neurotrophin-3 (NT3) to being dependent on nerve
growth factor (NGF) between E11 and E12 [13–16], E11
neurons were grown with either BDNF or NT3, and E12
neurons were grown with NGF.
Figure 1 shows that, at both ages, neurons from bcl-2–/–
embryos extended axons at a slower rate than those from
either bcl-2+/– or bcl-2+/+ embryos. After 48 h incubation,
bcl-2-deficient neurons were between 44 and 60% shorter
than wild-type neurons in E11 cultures and were 35%
shorter in E12 cultures. The differences in axonal length
between the neurons of bcl-2–/– and bcl-2+/+ embryos were
statistically significant at 12, 24 and 48 h incubation
(p < 0.0001 in all cases, using t tests; n = 124 in cultures of
E11 neurons grown with BDNF, n = 152 in cultures of
E11 neurons grown with NT3 and n = 197 in E12 cul-
tures). Neurons from bcl-2+/+ and bcl-2+/– embryos grew at
similar rates. Because only neurons that survived through-
out the 48 h period of study were included in the analysis,
differences in axonal growth rate between bcl-2-deficient
and wild-type embryos were not due to differences in sur-
vival. Even so, there were no significant differences in the
overall percentage survival of bcl-2-deficient and wild-type
neurons in these cohorts after 48 h incubation under
each experimental condition (E11 neurons plus BDNF,
wild-type = 55.4 ± 5.2%, bcl-2–/– = 54.1 ± 4.4%; E11 neurons
plus NT3, wild-type = 55.8 ± 2.9%, bcl-2–/– = 49.4 ± 1.6%;
E12 neurons plus NGF, wild-type = 59.3 ± 2.4%,
bcl-2–/– = 56.4 ± 2.6%; p > 0.05 in all cases, using t tests).
Furthermore, these results were not influenced by observer
bias, because the genotypes were ascertained after all mea-
surements were made. These results therefore suggest that
endogenous bcl-2 expression influences axonal growth rate
in early sensory neurons in culture. Additional comparative
studies of axonal growth rate in bcl-2 mutant and wild-type
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embryos in vivo will, however, be required in order to
assess further the significance of these in vitro observations.
Recent evidence suggests that the level of Bcl-2 expres-
sion in mouse retinal ganglion cells (RGCs) influences the
ability of these cells’ axons to regenerate into co-cultured
tectal explants [17]. At early fetal stages, RGCs express
high levels of Bcl-2 and are able to extend axons into co-
cultured tectal tissue of the same age, whereas late fetal
RGCs express low levels of Bcl-2 and are not able to grow
axons into tectal tissue. The regenerative ability of early
fetal RGCs is substantially reduced in retinal explants
obtained from bcl-2–/– embryos, and late fetal and adult
RGCs from transgenic mice overexpressing Bcl-2 in
neurons retain the ability to regenerate into tectal tissue.
Likewise, optic nerve axons in Bcl-2-overexpressing trans-
genic mice show enhanced regenerative capacity following
lesion in vivo [17]. Although these observations provide
evidence that Bcl-2 can promote axonal regeneration in
the central nervous system, their significance for the role
of endogenous Bcl-2 in the regulation of the growth of
axons to their target during development is uncertain.
Furthermore, because the numbers of regenerating RGCs,
rather than the growth rates of individual axons, were
measured in this study, it is unclear whether the level of
Bcl-2 expression affects the growth rate of regenerating
axons or simply affects the proportion of neurons that are
able to regenerate following axotomy.
Several previous studies of tumour cell lines have also
raised the possibility that Bcl-2 might play a role in
neuronal differentiation. First, Bcl-2 overexpression in a
neural crest-derived cell line enhanced the outgrowth of
neurite-like processes and increased the expression of
neuron-specific enolase [18]. Second, midbrain-derived
dopaminergic cell lines stably expressing bcl-2 extended
longer neurites than control transfected cells but did not
show increased expression of many neuron-specific pro-
teins [19]. Finally, Bcl-2 enhanced the differentiation of
the PC12 neural cell line into sympathetic-like neurons
when these cells were grown without serum but not when
grown with serum [20]. The physiological and develop-
mental significance of overexpressing bcl-2 in tumour cell
lines is, however, difficult to interpret.
In summary, our findings are consistent with a novel func-
tion for endogenously expressed bcl-2 in embryonic
sensory neurons shortly after they differentiate from prog-
enitor cells and start extending axons to their targets. At
this stage of development, bcl-2 appears to enhance the
rate of axonal growth. This action of bcl-2 is not related to
its well characterised anti-apoptotic role and may provide
an explanation for the widespread expression of bcl-2 in
embryonic nervous system during the earliest stages of
neuronal development [21,22], even though enhanced
degeneration of neurons in bcl-2-deficient mice is not
observed until the postnatal period [11].
Materials and methods
Mutant mice (bcl-2+/–) were a generous gift of Dennis Loh [2,3].
Embryos were obtained from overnight matings of bcl-2+/– mice. Preg-
nant females were killed after 11 and 12 days gestation and the geno-
types of the embryos were determined by a PCR-based technique
using DNA isolated from embryonic tissues. There were no consistent
differences in the stage of development of wild-type and bcl-2-deficient
embryos in each litter using the staging criteria of Theiler [23].
Separate dissociated cultures of trigeminal ganglion neurons were
established from each embryo. The neurons were cultured in 60 mm
diameter poly-ornithine/laminin-coated plastic tissue culture dishes at a
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Graphs showing the results of neuron cohort experiments to compare
axonal growth rates of trigeminal neurons from bcl-2+/+, bcl-2+/– and
bcl-2–/– embryos at (a,b) E11 and (c) E12. Neuron cohorts were
defined at 6 h and the overall neurite lengths of individual neurons in
these cohorts were measured at intervals up to 48 h. The means and
standard errors  are shown of serial measurements made on between
57 and 104 neurons of each genotype at each age (compiled from
cultures set up from the embryos of three separate litters at each age
comprising a total of 10 bcl-2+/+, 10 bcl-2+/– and 7 bcl-2–/– embryos
at E11 and 16 bcl-2+/+, 17 bcl-2+/– and 5 bcl-2–/– embryos at E12).
Where error bars are not shown, they would be smaller than the
symbols representing the different genotypes
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density of approximately 500 neurons per dish in 5 ml serum-free
medium [24]. Serial measurements of axonal length of the same
neurons were made at intervals between 6 and 48 h in culture by iden-
tifying the position of individual neurons within a grid drawn on the
underside of the dishes and making accurate serial drawings of the
axons of each neuron with the aid of a drawing tube [25]. The total
axon length of these bipolar sensory neurons was determined by
tracing the drawings onto a digitising pad linked to a computer. The
means and standard errors of the serial measurements taken from
cohorts of neurons in all experiments are reported. To exclude any dif-
ferences in axonal growth rate that could arise as a consequence of dif-
ferences in neuronal viability, only neurons that survived throughout the
48 h culture period were included in the analysis. The percentage sur-
vival in each cohort was also determined by counting the number of
neurons surviving in each cohort after 48 h and expressing this as a
percentage of the initial number of neurons in the cohort.
Acknowledgements
We thank Dennis Loh for providing the Bcl-2 mutant mice and Gene Burton
and John Winslow for providing the purified recombinant neurotrophins.
This work was supported by a grant from the Cancer Research Campaign.
References
1. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ: Bcl-2-deficient
mice demonstrate fulminant lymphoid apoptosis, polycystic
kidneys, and hypopigmented hair. Cell 1993, 75:229-240.
2. Nakayama K, Negishi I, Kud K, Shinkai Y, Louie MC, Fields LE, et al.:
Disappearance of the lymphoid system in Bcl-2 homozygous
mutant chimeric mice. Science 1993, 261:1584-1588.
3. Nakayama K, Nakayama K, Negishi I, Kuida K, Sawa H, Loh DY:
Targeted disruption of Bcl-2 alpha beta in mice: occurrence of
gray hair, polycystic kidney disease, and lymphocytopenia. Proc
Natl Acad Sci USA 1994, 91:3700-3704.
4. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP,
Korsmeyer SJ: bcl-2–immunoglobulin transgenic mice
demonstrate extended B cell survival and follicular
lymphoproliferation. Cell 1989, 57:79-88.
5. McDonnell TJ, Nunez G, Platt FM, Hockenberry D, London L, McKearn
JP, Korsmeyer SJ: Deregulated Bcl-2-immunoglobulin transgene
expands a resting but responsive immunoglobulin M and D-
expressing B-cell population. Mol Cell Biol 1990, 10:1901-1907.
6. Garcia I, Martinou I, Tsujimoto Y, Martinou JC: Prevention of
programmed cell death of sympathetic neurons by the bcl-2
proto-oncogene. Science 1992, 258:302-304.
7. Allsopp TE, Wyatt S, Paterson HF, Davies AM: The proto-oncogene
bcl-2 can selectively rescue neurotrophic factor-dependent
neurons from apoptosis. Cell 1993, 73:295-307.
8. Martinou JC, Dubois-Dauphin M, Staple JK, Rodriquez I, Frankosky H,
Missotten M, et al.: Overexpression of bcl-2 in transgenic mice
protects neurons from naturally occurring cell death and
experimental ischaemia. Neuron 1994, 13:1017-1030.
9. Allsopp TE, Kiselev S, Wyatt S, Davies AM: Role of Bcl-2 expression
in the BDNF survival response. Eur J Neurosci 1995, 7:1266-1272.
10. Greenlund LJ, Korsmeyer SJ, Johnson EM: Role of BCL-2 in the
survival and function of developing and mature sympathetic
neurons. Neuron 1995, 15:649-661.
11. Michaelidis TM, Sendtner M, Cooper JD, Airaksinen MS, Holtmann B,
Meyer M, Thoenen H: Inactivation of bcl-2 results in progressive
degeneration of motoneurons, sympathetic neurons and sensory
neurons during the early postnatal development. Neuron 1996,
17:75-89.
12. Davies AM, Lumsden AGS: Relation of target encounter and
neuronal death to nerve growth factor responsiveness in the
developing mouse trigeminal ganglion. J Comp Neurol 1984,
223:124-137.
13. Paul G, Davies AM: Trigeminal sensory neurons require extrinsic
signals to switch neurotrophin dependence during the early
stages of target field innervation. Dev Biol 1995, 171:590-605.
14. Buchman VL, Davies AM: Different neurotrophins are expressed
and act in a developmental sequence to promote the survival of
embryonic sensory neurons. Development 1993, 118:989-1001.
15. Pinon LGP, Minichiello L, Klein R, Davies AM: Timing of neuronal
death in trkA, trkB and trkC mutant embryos reveals
developmental changes in sensory neuron dependence on Trk
signalling. Development 1996, 122:3255-3261.
16. Wilkinson GA, Fariñas I, Backus C, Yoshida CK, Reichardt LF:
Neurotrophin-3 is a survival factor in vivo for early mouse
trigeminal neurons. J Neurosci 1996, 16:7661-7669.
17. Chen DF, Schneider GE, Martinou JC, Tonegawa S: Bcl-2 promotes
regeneration of severed axons in mammalian CNS. Nature 1997,
385:434-439.
18. Zhang KZ, Westberg JA, Holtta E, Andersson LC: BCL2 regulates
neural differentiation. Proc Natl Acad Sci USA 1996, 93:4504-
4508.
19. Oh YJ, Swarzenski BC, O’Malley KL: Overexpression of Bcl-2 in a
murine dopaminergic neuronal cell line leads to neurite
outgrowth. Neurosci Lett 1996, 202:161-164.
20. Batistatou A, Merry DE, Korsmeyer SJ, Greene LA: Bcl-2 affects
survival but not neuronal differentiation of PC12 cells. J Neurosci
1993, 13:4422-4428.
21. Abe DS, Harada N, Yamada K, Tanaka R: Bcl-2 gene is highly
expressed during neurogenesis in the central nervous system.
Biochem Biophys Res Commun 1993, 191:915-921.
22. Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ: bcl-2 protein
expression is widespread in the developing nervous system and
retained in the adult PNS. Development 1994, 120:301-311.
23. Theiler K: The House Mouse (Development and Normal Stages from
Fertilisation to 4 Weeks). Berlin: Springer; 1972.
24. Davies AM, Lee KF, Jaenisch R: p75-deficient trigeminal sensory
neurons have an altered response to NGF but not to other
neurotrophins. Neuron 1993, 11:565-574.
25. Davies AM: Intrinsic differences in the growth rate of early nerve
fibres related to target distance. Nature 1989, 337:553-555.
